CTC Alternative Strategies »

G1 Therapeutics shares owned by CTC Alternative Strategies

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by CTC Alternative Strategies from 13F filings

Historical chart of CTC Alternative Strategies investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by CTC Alternative Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by CTC Alternative Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $52k 12k 4.32

More positions owned by CTC Alternative Strategies

Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Bitcoin Tr SHS
Ishares Tr Tips Bd Etf (TIP)
Ishares Tr Mbs Etf (MBB)
Callon Petroleum (CPE)
Ishares Tr Iboxx Hi Yd Etf (HYG)
CRH Ord (CRH)
Dell Technologies CL C (DELL)
Packaging Corporation of America (PKG)
Abbott Laboratories (ABT)
Kimberly-Clark Corporation (KMB)
Spirit Aerosystems Hldgs Com Cl A (SPR)
Martin Marietta Materials (MLM)
Raymond James Financial (RJF)
Genuine Parts Company (GPC)

View all positions for CTC Alternative Strategies

Top funds holding G1 Therapeutics

Vanguard Group
Susquehanna International
Raymond James & Associates
D. E. Shaw & Co
BlackRock
Geode Capital Management
Goldman Sachs Group
Millennium Management
Acadian Asset Management
Standard Life Aberdeen
Connor, Clark & Lunn Investment Management
HAP Trading
Bank of America Corporation
Jacobs Levy Equity Management
Caption Management

View all funds holding G1 Therapeutics